72 related articles for article (PubMed ID: 11848539)
41. Lymphoma.
Curr Opin Oncol; 1994 Sep; 6(5):B229-38. PubMed ID: 7827143
[No Abstract] [Full Text] [Related]
42. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
43. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
44. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
[TBL] [Abstract][Full Text] [Related]
45. [Classification and differential diagnosis of NK/T-cell lymphomas].
Feller AC
Verh Dtsch Ges Pathol; 2003; 87():43-52. PubMed ID: 16888893
[TBL] [Abstract][Full Text] [Related]
46. Dysregulative lymphoma theory revisited; what can we learn from cytokines, CD classes and genes?
Krueger GR; Nguyen AN; Uthman M; Brandt ME; Buja LM
Anticancer Res; 2001; 21(5):3653-61. PubMed ID: 11848539
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory cells and immune microenvironment in malignant lymphoma.
de Jong D; Enblad G
J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
[TBL] [Abstract][Full Text] [Related]
48. [Classification of lymphomas].
Molina T; Diebold J; Audouin J
Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
[TBL] [Abstract][Full Text] [Related]
49. DCs in lymphoma--biology and therapeutic aspects.
Schultze JL; Fiore F; von Bergwelt-Baildon M
Cytotherapy; 2004; 6(2):138-47. PubMed ID: 15203990
[No Abstract] [Full Text] [Related]
50. Host immune response in B-cell lymphomas: friend or foe?
Juszczyński P; Nowak J; Warzocha K
Arch Immunol Ther Exp (Warsz); 2008; 56(4):245-55. PubMed ID: 18726146
[TBL] [Abstract][Full Text] [Related]
51. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
52. Animal models of intraocular lymphomas.
Touitou V; Bodaghi B; de Kozak Y; Lehoang P; Sautès-Fridman C; Fisson S
Ophthalmic Res; 2008; 40(3-4):208-11. PubMed ID: 18421241
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
